| Full Name | Andre Cruz |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 400 N Pepper Ave, Colton, California |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669865382 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 708797 (California) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 95000322 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inland Empire Anesthesia Medical Group, Inc | 1052310331 | 26 |
| Raelle Anesthesia Inc | 8123260874 | 2 |
News Archive
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
The Russian government has approved a five-year, $2.9 billion draft program to combat diseases, including HIV/AIDS, in an effort to improve the country's life expectancy, a spokesperson announced on Thursday, the AP/Guardian reports (AP/Guardian, 2/23).
A new study presented today at the International Liver Congress- 2012 indicates the potential for gallbladder tissue (which is routinely discarded from organ donors and surgical interventions) to be a highly available candidate source for multipotential stem cells.
The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes
› Verified 3 days ago
| Entity Name | Inland Empire Anesthesia Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861502841 PECOS PAC ID: 1052310331 Enrollment ID: O20061214000268 |
News Archive
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
The Russian government has approved a five-year, $2.9 billion draft program to combat diseases, including HIV/AIDS, in an effort to improve the country's life expectancy, a spokesperson announced on Thursday, the AP/Guardian reports (AP/Guardian, 2/23).
A new study presented today at the International Liver Congress- 2012 indicates the potential for gallbladder tissue (which is routinely discarded from organ donors and surgical interventions) to be a highly available candidate source for multipotential stem cells.
The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes
› Verified 3 days ago
| Entity Name | Raelle Anesthesia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437499266 PECOS PAC ID: 8123260874 Enrollment ID: O20130809000303 |
News Archive
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
The Russian government has approved a five-year, $2.9 billion draft program to combat diseases, including HIV/AIDS, in an effort to improve the country's life expectancy, a spokesperson announced on Thursday, the AP/Guardian reports (AP/Guardian, 2/23).
A new study presented today at the International Liver Congress- 2012 indicates the potential for gallbladder tissue (which is routinely discarded from organ donors and surgical interventions) to be a highly available candidate source for multipotential stem cells.
The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes
› Verified 3 days ago
| Entity Name | Coachella Valley Anesthesia A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013662048 PECOS PAC ID: 5698131969 Enrollment ID: O20230512000330 |
News Archive
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
The Russian government has approved a five-year, $2.9 billion draft program to combat diseases, including HIV/AIDS, in an effort to improve the country's life expectancy, a spokesperson announced on Thursday, the AP/Guardian reports (AP/Guardian, 2/23).
A new study presented today at the International Liver Congress- 2012 indicates the potential for gallbladder tissue (which is routinely discarded from organ donors and surgical interventions) to be a highly available candidate source for multipotential stem cells.
The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andre Cruz, 7201 S Sepulveda Blvd, Los Angeles, CA 90045-1514 Ph: () - | Andre Cruz, 400 N Pepper Ave, Colton, CA 92324-1801 Ph: (909) 580-1000 |
News Archive
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
The Russian government has approved a five-year, $2.9 billion draft program to combat diseases, including HIV/AIDS, in an effort to improve the country's life expectancy, a spokesperson announced on Thursday, the AP/Guardian reports (AP/Guardian, 2/23).
A new study presented today at the International Liver Congress- 2012 indicates the potential for gallbladder tissue (which is routinely discarded from organ donors and surgical interventions) to be a highly available candidate source for multipotential stem cells.
The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes
› Verified 3 days ago
Mr. Richard William Reis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 North Pepper Avenue 2nd Floor, Anesthesia Dept., Inland Empire Anesthesia Medical Group, Inc., Colton, CA 92324 Phone: 909-580-2440 Fax: 909-580-2441 | |
Elizabeth Karenina Manullang, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 877-873-2762 | |
Ivan Stiger, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-2440 | |
Mr. Michael T Reid, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 E Washington St, Ste. 100, Colton, CA 92324 Phone: 909-370-2190 | |
Daniel Hioe, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-2440 | |
Mr. Dale Arthur Reile, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 400 N Pepper Ave Fl 2, Inland Empire Anesthesia Medical Group, Inc., Colton, CA 92324 Phone: 909-580-2440 Fax: 909-580-2441 | |
Cheryl Sisler Carr, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 400 N Pepper Ave, Anesthesia Dept, 2nd Floor, Colton, CA 92324 Phone: 909-580-2440 |